{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T16:21:28Z","timestamp":1717604488622},"reference-count":31,"publisher":"Pharmaceutical Society of Japan","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2020,4,1]]},"DOI":"10.1248\/bpb.b19-00818","type":"journal-article","created":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T22:10:37Z","timestamp":1585692637000},"page":"639-648","source":"Crossref","is-referenced-by-count":7,"title":["Increased Expression of Sema3C Indicates a Poor Prognosis and Is Regulated by miR-142-5p in Glioma"],"prefix":"10.1248","volume":"43","author":[{"given":"Haidong","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Neurology, Jining NO.1 People\u2019s Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Neurology, Jining NO.1 People\u2019s Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenling","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Jining NO.1 People\u2019s Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deyi","family":"Duan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Jining NO.1 People\u2019s Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangting","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Jining NO.1 People\u2019s Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Jining NO.1 People\u2019s Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Jining NO.1 People\u2019s Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Wen PY, Kesari S. Malignant gliomas in adults. <i>N. Engl. J. Med.<\/i>, <b>359<\/b>, 492\u2013507 (2008).","DOI":"10.1056\/NEJMra0708126"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Blanc V, Nariculam J, Munson P, Freeman A, Klocker H, Masters J, Williamson M. A role for class 3 semaphorins in prostate cancer. <i>Prostate<\/i>, <b>71<\/b>, 649\u2013658 (2011).","DOI":"10.1002\/pros.21281"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Flannery E, Duman-Scheel M. Semaphorins at the interface of development and cancer. <i>Curr. Drug Targets<\/i>, <b>10<\/b>, 611\u2013619 (2009).","DOI":"10.2174\/138945009788680383"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Gaur P, Bielenberg DR, Samuel S, Bose D, Zhou Y, Gray MJ, Dallas NA, Fan F, Xia L, Lu J, Ellis LM. Role of class 3 semaphorins and their receptors in tumor growth and angiogenesis. <i>Clin. Cancer Res.<\/i>, <b>15<\/b>, 6763\u20136770 (2009).","DOI":"10.1158\/1078-0432.CCR-09-1810"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Vaitkien\u0117 P, Skiriute D, Steponaitis G, Skauminas K, Tamasauskas A, Kazlauskas A. High level of Sema3C is associated with glioma malignancy. <i>Diagn. Pathol.<\/i>, <b>10<\/b>, 58 (2015).","DOI":"10.1186\/s13000-015-0298-9"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Man J, Shoemake J, Zhou W, Fang X, Wu Q, Rizzo A, Prayson R, Bao S, Rich JN, Yu JS. Sema3C promotes the survival and tumorigenicity of glioma stem cells through Rac1 activation. <i>Cell Reports<\/i>, <b>9<\/b>, 1812\u20131826 (2014).","DOI":"10.1016\/j.celrep.2014.10.055"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Miyato H, Tsuno NH, Kitayama J. Semaphorin 3C is involved in the progression of gastric cancer. <i>Cancer Sci.<\/i>, <b>103<\/b>, 1961\u20131966 (2012).","DOI":"10.1111\/cas.12003"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Zhang Y, Dutta A, Abounader R. The role of microRNAs in glioma initiation and progression. <i>Front. Biosci. <\/i>(Landmark Ed.), <b>17<\/b>, 700\u2013712 (2012).","DOI":"10.2741\/3952"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Yang CH, Yue J, Pfeffer SR, Fan M, Paulus E, Hosni-Ahmed A, Sims M, Qayyum S, Davidoff AM, Handorf CR, Pfeffer LM. MicroRNA-21 promotes glioblastoma tumorigenesis by down-regulating insulin-like growth factor-binding protein-3 (IGFBP3). <i>J. Biol. Chem.<\/i>, <b>289<\/b>, 25079\u201325087 (2014).","DOI":"10.1074\/jbc.M114.593863"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Yan Z, Che S, Wang J, Jiao Y, Wang C, Meng Q. miR-155 contributes to the progression of glioma by enhancing Wnt\/beta-catenin pathway. <i>Tumour Biol.<\/i>, <b>36<\/b>, 5323\u20135331 (2015).","DOI":"10.1007\/s13277-015-3193-9"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Wang Q, Li X, Zhu Y, Yang P. MicroRNA-16 suppresses epithelial-mesenchymal transitionrelated gene expression in human glioma. <i>Molecular Medicine Reports<\/i>, <b>10<\/b>, 3310\u20133314 (2014).","DOI":"10.3892\/mmr.2014.2583"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Tu Y, Gao X, Li G, Fu H, Cui D, Liu H, Jin W, Zhang Y. MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1. <i>Cancer Res.<\/i>, <b>73<\/b>, 6046\u20136055 (2013).","DOI":"10.1158\/0008-5472.CAN-13-0358"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Xu S, Wei J, Wang F, Kong LY, Ling XY, Nduom E, Gabrusiewicz K, Doucette T, Yang Y, Yaghi NK, Fajt V, Levine JM, Qiao W, Li XG, Lang FF, Rao G, Fuller GN, Calin GA, Heimberger AB. Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma. <i>J. Natl. Cancer Inst.<\/i>, <b>106<\/b>, dju162 (2014).","DOI":"10.1093\/jnci\/dju162"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Qin W, Rong X, Dong J, Yu C, Yang J. miR-142 inhibits the migration and invasion of glioma by targeting Rac1. <i>Oncol. Rep.<\/i>, <b>38<\/b>, 1543\u20131550 (2017).","DOI":"10.3892\/or.2017.5816"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Wang L, Song G, Chang X, Tan W, Pan J, Zhu X, Liu Z, Qi M, Yu J, Han B. The role of TXNDC5 in castration-resistant prostate cancer-involvement of androgen receptor signaling pathway. <i>Oncogene<\/i>, <b>34<\/b>, 4735\u20134745 (2015).","DOI":"10.1038\/onc.2014.401"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Wang L, Song G, Zheng Y, Wang D, Dong H, Pan J, Chang X. miR-573 is a negative regulator in the pathogenesis of rheumatoid arthritis. <i>Cell. Mol. Immunol.<\/i>, <b>13<\/b>, 839\u2013849 (2016).","DOI":"10.1038\/cmi.2015.63"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Wang L, Song G, Zheng Y, Tan W, Pan J, Zhao Y, Chang X. Expression of Semaphorin 4A and its potential role in rheumatoid arthritis. <i>Arthritis Res. Ther.<\/i>, <b>17<\/b>, 227 (2015).","DOI":"10.1186\/s13075-015-0734-y"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Wang L, Zheng Y, Xu H, Yan X, Chang X. Investigate pathogenic mechanism of TXNDC5 in rheumatoid arthritis. <i>PLOS ONE<\/i>, <b>8<\/b>, e53301 (2013).","DOI":"10.1371\/journal.pone.0053301"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Wang L, Zhang J, Yang X, Chang YW, Qi M, Zhou Z, Zhang J, Han B. SOX4 is associated with poor prognosis in prostate cancer and promotes epithelial\u2013mesenchymal transition <i>in vitro.<\/i> <i>Prostate Cancer Prostatic Dis.<\/i>, <b>16<\/b>, 301\u2013307 (2013).","DOI":"10.1038\/pcan.2013.25"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Wang L, Li Y, Yang X, Yuan H, Li X, Qi M, Chang YW, Wang C, Fu W, Yang M, Zhang J, Han B. ERG-SOX4 interaction promotes epithelial\u2013mesenchymal transition in prostate cancer cells. <i>Prostate<\/i>, <b>74<\/b>, 647\u2013658 (2014).","DOI":"10.1002\/pros.22783"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Herman JG, Meadows GG. Increased class 3 semaphorin expression modulates the invasive and adhesive properties of prostate cancer cells. <i>Int. J. Oncol.<\/i>, <b>30<\/b>, 1231\u20131238 (2007).","DOI":"10.3892\/ijo.30.5.1231"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Cole-Healy Z, Vergani P, Hunter K, Brown NJ, Reed MW, Staton CA. The relationship between semaphorin 3C and microvessel density in the progression of breast and oral neoplasia. <i>Exp. Mol. Pathol.<\/i>, <b>99<\/b>, 19\u201324 (2015).","DOI":"10.1016\/j.yexmp.2015.03.041"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Olar A, Sulman EP. Molecular markers in low-grade glioma-toward tumor reclassification. <i>Semin. Radiat. Oncol.<\/i>, <b>25<\/b>, 155\u2013163 (2015).","DOI":"10.1016\/j.semradonc.2015.02.006"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Kahlert UD, Nikkhah G, Maciaczyk J. Epithelial-to-mesenchymal(-like) transition as a relevant molecular event in malignant gliomas. <i>Cancer Lett.<\/i>, <b>331<\/b>, 131\u2013138 (2013).","DOI":"10.1016\/j.canlet.2012.12.010"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Wong JW. MicroRNA-induced silencing of glioma progression. <i>J. Neurosci.<\/i>, <b>30<\/b>, 3868\u20133869 (2010).","DOI":"10.1523\/JNEUROSCI.0442-10.2010"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Urbich C, Kaluza D, Fromel T, Knau A, Bennewitz K, Boon RA, Bonauer A, Doebele C, Boeckel JN, Hergenreider E, Zeiher AM, Kroll J, Fleming I, Dimmeler S. MicroRNA-27a\/b controls endothelial cell repulsion and angiogenesis by targeting semaphorin 6A. <i>Blood<\/i>, <b>119<\/b>, 1607\u20131616 (2012).","DOI":"10.1182\/blood-2011-08-373886"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Yan-Chun L, Hong-Mei Y, Zhi-Hong C, Qing H, Yan-Hong Z, Ji-Fang W. MicroRNA-192-5p Promote the proliferation and metastasis of hepatocellular carcinoma cell by targeting SEMA3A. <i>Appl. Immunohistochem. Mol. Morphol.<\/i>, <b>25<\/b>, 251\u2013260 (2017).","DOI":"10.1097\/PAI.0000000000000296"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Ghanbari R, Mosakhani N, Asadi J, Nouraee N, Mowla SJ, Yazdani Y, Mohamadkhani A, Poustchi H, Knuutila S, Malekzadeh R. Downregulation of plasma MiR-142-3p and MiR-26a-5p in patients with colorectal carcinoma. <i>Iranian Journal of Cancer Prevention<\/i>, <b>8<\/b>, e2329 (2015).","DOI":"10.17795\/ijcp2329"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Chen FF, Lou YJ, Chen J, Jin J, Zhou JN, Yin XF, Zhu ZJ, Hu C, Yu MX, Wang HP, Jin J. Absence of miR-142 mutation in Chinese patients with acute myeloid leukemia. <i>Leuk. Lymphoma<\/i>, <b>55<\/b>, 2961\u20132962 (2014).","DOI":"10.3109\/10428194.2014.907892"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Zhang X, Yan Z, Zhang J, Gong L, Li W, Cui J, Liu Y, Gao Z, Li J, Shen L, Lu Y. Combination of hsa-miR-375 and hsa-miR-142-5p as a predictor for recurrence risk in gastric cancer patients following surgical resection. <i>Ann. Oncol.<\/i>, <b>22<\/b>, 2257\u20132266 (2011).","DOI":"10.1093\/annonc\/mdq758"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Ouyang Q, Xu L, Cui H, Xu M, Yi L. MicroRNAs and cell cycle of malignant glioma. <i>Int. J. Neurosci.<\/i>, <b>126<\/b>, 1\u20139 (2016).","DOI":"10.3109\/00207454.2015.1017881"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/4\/43_b19-00818\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T03:22:58Z","timestamp":1585970578000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/4\/43_b19-00818\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,1]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b19-00818","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,1]]}}}